Copper 63-65 for a Healthier Tomorrow
Pioneering high-purity isotope solutions for advanced cancer diagnostics and research.
Targeted Imaging
Cu‑64 enables tumor-specific scans that detect cancer earlier and more accurately.
Theranostics
The Cu‑64 / Cu‑67 pair allows one compound to both find and fight cancer cells.
Radiolabeling
Copper isotopes help precisely guide biologics to tumors for imaging or therapy
Dosimetry
Real-time copper tracking allows for safer, customized cancer treatment plans.
Our Mission
Element 29 is a proud Canadian company dedicated to producing ultra-pure copper isotopes that are transforming the way cancer is diagnosed and treated. Our mission goes beyond scientific innovation—we are driven by a commitment to global health equity. By partnering with world-class institutions and reinvesting in medical research and access, we aim to ensure that the life-saving potential of copper-based technologies reaches the people and communities who need it most.
Copper‑63 (Cu‑63)
Copper‑63 is a stable, non-radioactive isotope of copper that plays a critical role as the starting material for producing medical isotopes like Copper‑64 (Cu‑64) and Copper‑67 (Cu‑67). With an atomic abundance of approximately 69%, Cu‑63 is enriched to high purity for use in cyclotron targets and isotope separation processes. These downstream isotopes are essential in PET imaging and radiopharmaceutical therapy, enabling early cancer detection and targeted treatment. High-purity Cu‑63 is the foundation of Element 29’s work, supporting the next generation of medical diagnostics and theranostics.
Copper‑65 (Cu‑65)
Copper‑65 is the naturally occurring companion isotope to Cu‑63, making up about 31% of natural copper. While Cu‑65 is not typically used directly in medical isotope production, it is an important byproduct of Cu‑63 enrichment. At Element 29, we are exploring ways to donate or repurpose Cu‑65 for scientific research and educational use, ensuring that every part of the enrichment process contributes to broader scientific and humanitarian goals. This aligns with our commitment to sustainability and giving back to the research community.
Working Together for Global Impact
At Element 29, we believe that meaningful breakthroughs happen through collaboration. Whether you’re a research institution, healthcare innovator, or industry leader, we welcome the opportunity to work together toward a shared goal: advancing cancer diagnostics and treatment through ultra-pure copper isotopes.
We’re building a network of partners who are just as committed to innovation, access, and impact as we are. From research trials to medical applications, your expertise combined with our materials can help push the boundaries of what’s possible in modern healthcare.